Unknown

Dataset Information

0

Design, Synthesis and Anticancer Activity of a New Series of N-aryl-N'-[4-(pyridin-2-ylmethoxy)benzyl]urea Derivatives.

ABSTRACT: The development of cancer treatments requires continuous exploration and improvement, in which the discovery of new drugs for the treatment of cancer is still an important pathway. In this study, based on the molecular hybridization strategy, a new structural framework with an N-aryl-N'-arylmethylurea scaffold was designed, and 16 new target compounds were synthesized and evaluated for their antiproliferative activities against four different cancer cell lines A549, MCF7, HCT116, PC3, and human liver normal cell line HL7702. The results have shown seven compounds with 1-methylpiperidin-4-yl groups having excellent activities against all four cancer cell lines, and they exhibited scarcely any activities against HL7702. Among them, compound 9b and 9d showed greatly excellent activity against the four kinds of cells, and the IC50 for MCF7 and PC3 cell lines were even less than 3 μM.

SUBMITTER: Hou S 

PROVIDER: S-EPMC8226862 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Design, Synthesis and Anticancer Activity of a New Series of <i>N</i>-aryl-<i>N</i>'-[4-(pyridin-2-ylmethoxy)benzyl]urea Derivatives.

Hou Shicheng S   Liang Shishao S   Zhang Chao C   Han Yingmei Y   Liang Jianhui J   Hu Hongyu H   Zhang Xingeng X   Hu Chun C   Liu Xiaoping X   Zhang Hong H  

Molecules (Basel, Switzerland) 20210608 12

The development of cancer treatments requires continuous exploration and improvement, in which the discovery of new drugs for the treatment of cancer is still an important pathway. In this study, based on the molecular hybridization strategy, a new structural framework with an <i>N</i>-aryl-<i>N</i>'-arylmethylurea scaffold was designed, and 16 new target compounds were synthesized and evaluated for their antiproliferative activities against four different cancer cell lines A549, MCF7, HCT116, P  ...[more]

Similar Datasets

Unknown Synthesis and biological evaluation of a new series of 1-aryl-3-[4-(pyridin-2-ylmethoxy)phenyl]urea derivatives as new anticancer agents.
| S-EPMC7232929 | biostudies-literature
Unknown Design, Synthesis and Biological Evaluation of a New Series of 1-Aryl-3-{4-[(pyridin-2-ylmethyl)thio]phenyl}urea Derivatives as Antiproliferative Agents.
| S-EPMC6600452 | biostudies-literature
Unknown Design, Synthesis, and Biological Evaluation of Novel Urea-Containing Carnosic Acid Derivatives with Anticancer Activity.
| S-EPMC11728001 | biostudies-literature
Unknown Design, Synthesis and Preliminary Biological Evaluation of Novel Benzyl Sulfoxide 2-Indolinone Derivatives as Anticancer Agents.
| S-EPMC6150246 | biostudies-literature
Unknown Novel quinazolines bearing 1,3,4-thiadiazole-aryl urea derivative as anticancer agents: design, synthesis, molecular docking, DFT and bioactivity evaluations.
| S-EPMC10863284 | biostudies-literature
Unknown Design, synthesis and anticancer activity of naphthoquinone derivatives.
| S-EPMC7144209 | biostudies-literature
Unknown Design, Synthesis and Biological Evaluation of 6-(Imidazo[1,2-a]pyridin-6-yl)quinazoline Derivatives as Anticancer Agents via PI3Kα Inhibition.
| S-EPMC10095550 | biostudies-literature
Unknown Synthesis and biological properties of a series of aryl alkyl disulfide derivatives.
| S-EPMC7644900 | biostudies-literature
Unknown The Design and Synthesis of a New Series of 1,2,3-Triazole-Cored Structures Tethering Aryl Urea and Their Highly Selective Cytotoxicity toward HepG2.
| S-EPMC9147274 | biostudies-literature
Unknown Design, synthesis, in vitro anticancer, molecular docking and SAR studies of new series of pyrrolo[2,3-d]pyrimidine derivatives.
| S-EPMC10463376 | biostudies-literature